Protalix BioTherapeutics, Inc. PLX
Set alert
2.60 USD +0.04 +1.37%
As of Nov 3, 10:40 AM ET
2.57 Day range 2.61
1.65 52-week range 3.19
- YTD
- +44.17%
- 1 year
- +8.58%
- Open
- 2.57
- Prev close
- 2.56
- Mkt cap
- 209.08M
- Vol
- 32.11K
- Avg vol
- 780.72K
- EPS
- 0.23
- P/E
- 11.28
- Div yield
- 0.00%
More statistics
- Low
- 2.57
- High
- 2.61
- Forward P/E
- 2.79
- Beta
- 0.67
- Short ratio
- 22.71
- Inst. own
- 5.20%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.43
- 200-d avg
- 1.21
- 1y target
- 14.00
Analyst view
Consensus: none
Price target (mean) 14.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 18.21M | +73.6% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 53.39M | -18.5% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 101.44M | +90.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |